Skip to primary content
Skip to secondary content

Biotech 365

Main menu

  • Biotech 365
  • Biotech Companies
  • Healthcare Investors
  • Pharma News
  • Market Size & Market Analysis
  • Biotech Jobs

Tag Archives: Aduro

Aduro Biotech – engineered Immunotherapy for Cancer

Posted on by

Aduro Biotech is a clinical-stage cancer immunotherapy company with multiple therapeutic approaches in development that have the potential to yield powerful immunotherapy combinations.

Aduro Biotech – engineered Immunotherapy for Cancer

Aduro Biotech

Continue reading →

Posted in Biotech Companies, Biotech Companies America, Biotech Companies Clinical Stage, Biotech Companies Diabetes, Biotech Companies Drug Development, Biotech Companies Metabolism, Biotech Companies Monoclonal Antibodies mAbs, Biotech Companies Oncology Cancer, Biotech Companies Pancreatic Cancer, Biotech Companies Therapeutics, Biotech Companies USA | Tagged Aduro, Aduro Biotech, Aduro Biotech - engineered Immunotherapy for Cancer, B-select, B-select antibodies, B-select antibody, cancer immunotherapy, CDN, CDNs, CRS-207, cyclic dinucleotide, cyclic dinucleotides, engineered Immunotherapy Cancer, engineered Immunotherapy for Cancer, GVAX Pancreas, LADD, live attenuated double-deleted Listeria mononcytogenes, metastatic pancreatic cancer

Do you need to raise your next Funding round ? In-Licensing / Out-Licensing of your assets ? Want to create a spin-off with your IP ? Contact us!

Do you need access to our Healthcare database (investors, companies, CRO/CDMO, distributors, market analysis, etc.) ?   Contact us for more details and check our free DEMO.

Do you need to compare several quotes from CRO / CDMO ? We can help you for free ! Contact us .

Offers - Services - Licensing - Funding               Healthcare Venture Building               Biotech Jobs               Biotech & Pharma News              BioLeads
Proudly powered by WordPress